Center-Authored Papers

Filters: Author is Huebner, Dirk  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2014
Bartlett NL, Chen R, Fanale MA, Brice P, Gopal A, Smith SE, Advani R, Matous JV, Ramchandren R, Rosenblatt JD et al..  2014.  Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.. Journal of hematology & oncology. 7(1):24. Abstract
Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Huebner D et al..  2014.  Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(28):3137-43. Abstract
April 2014
Bartlett NL, Chen R, Fanale MA, Brice P, Gopal A, Smith SE, Advani R, Matous JV, Ramchandren R, Rosenblatt JD et al..  2014.  Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.. Journal of hematology & oncology. 7(1):24. Abstract
Clinical Research Division
Bartlett NL, Chen R, Fanale MA, Brice P, Gopal A, Smith SE, Advani R, Matous JV, Ramchandren R, Rosenblatt JD et al..  2014.  Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.. Journal of hematology & oncology. 7(1):24. Abstract
Shared Resources
Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Huebner D et al..  2014.  Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(28):3137-43. Abstract
Specimen Processing Core Facility
Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Huebner D et al..  2014.  Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(28):3137-43. Abstract